Why the study?
Loss of the normal nocturnal blood pressure fall is prevalent in T2DM, where endothelial impairment, microvascular injury, and autonomic dysregulation coexist. This study evaluated the association between the Endothelial Activation and Stress Index (EASIX), an accessible laboratory composite, and a non-dipping blood pressure pattern in T2DM patients with newly diagnosed hypertension.
Population
380 patients with T2DM undergoing 24-hour ABPM
Comparison
Non-dipper hypertension vs dipper hypertension vs normotensive diabetic controls
Design
Retrospective observational analysis
Answers are grounded in this paper and cite their sources.
Retrospective study shows elevated EASIX independently predicts a non-dipping blood pressure pattern in type 2 diabetes, suggesting its utility in cardiovascular risk stratification.
Background: Loss of the normal nocturnal blood pressure fall is an adverse circadian phenotype associated with heightened cardiovascular morbidity. This pattern is particularly prevalent in type 2 diabetes mellitus (T2DM), where endothelial impairment, microvascular injury, and autonomic dysregulation frequently coexist. The Endothelial Activation and Stress Index (EASIX), calculated from lactate dehydrogenase (LDH), creatinine, and platelet count, is an accessible laboratory composite integrating cellular injury, renal function, and platelet-related vascular information. Methods: This retrospective observational analysis screened consecutive patients with T2DM who underwent 24-hour ambulatory blood pressure monitoring (ABPM) between December 2024 and April 2026. After applying predefined eligibility criteria, 380 participants were included: 127 patients with non-dipper hypertension, 127 with dipper hypertension, and 126 normotensive diabetic controls. EASIX was calculated as (LDH × creatinine) / platelet count and transformed using the base-2 logarithm. Statistical analyses included Dunn-Bonferroni post-hoc pairwise comparisons, multivariable logistic regression, sensitivity modeling excluding nocturnal blood pressure, incremental discrimination assessment (ΔAUC, net reclassification improvement [NRI], integrated discrimination improvement [IDI]), ROC analysis, bootstrap internal validation, and decision curve analysis. Results: EASIX and log 2 (EASIX) were significantly elevated in non-dipper hypertensive patients compared with both dipper hypertensive patients (post-hoc adjusted p < 0.001) and normotensive diabetic controls (post-hoc adjusted p < 0.001). In multivariable logistic regression, log 2 (EASIX) independently predicted non-dipper status after adjusting for age, sex, BMI, HbA1c, absolute nighttime systolic blood pressure, smoking, and coronary artery disease (adjusted OR: 5.864, 95% CI: 3.182– 10.809, p < 0.001). In a sensitivity model excluding nighttime systolic blood pressure to prevent potential structural dependence, log 2 (EASIX) remained an independent predictor (adjusted OR: 5.412, 95% CI: 2.998– 9.768, p < 0.001). Adding log 2 (EASIX) to a baseline clinical model significantly improved discriminative performance (AUC increased from 0.612 to 0.751, ΔAUC = +0.139, p < 0.001), with a continuous NRI of 0.584 (p < 0.001) and an IDI of 0.142 (p < 0.001). Conclusion: In patients with T2DM and newly diagnosed hypertension, elevated EASIX is independently associated with the non-dipper blood pressure pattern and provides incremental predictive value beyond conventional clinical factors. EASIX represents an inexpensive, readily obtainable laboratory composite that may assist in the early risk stratification of diabetic patients requiring detailed ambulatory blood pressure assessment.
No takes yet. Share an insight, caveat, or question.
Keleş et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: